A possible physiological pathway involves abnormal increases in soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), accompanied by a decrease in placental growth factor (PlGF), which have been implicated in the pathogenesis of preeclampsia [20–22]. The gene discussed is FLT1; the disease is preeclampsia.